Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

View All Documentation

P0048

Sigma-Aldrich

Pemoline

≥98% (HPLC)

Sinonimo/i:

2-Amino-5-phenyl4(5H)-oxazolone, Phenylisohydantoin

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C9H8N2O2
Numero CAS:
2152-34-3
Peso molecolare:
176.17
Numero CE:
218-438-8
Numero MDL:
MFCD00083197
Codice UNSPSC:
12352200
ID PubChem:
329819998
NACRES:
NA.77

Saggio

≥98% (HPLC)

Forma fisica

solid

Controllo stupefacenti

USDEA Schedule IV; Home Office Schedule 4.2; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

Solubilità

DMSO: 28 mg/mL

Ideatore

Boehringer Ingelheim

Temperatura di conservazione

2-8°C

Stringa SMILE

NC1=NC(=O)C(O1)c2ccccc2

InChI

1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)
NRNCYVBFPDDJNE-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Azioni biochim/fisiol

Pemoline is a CNS stimulant. Pemoline is used to treat attention-deficit hyperactivity disorder (ADHD). Pemoline is a Schedule IV drug and offers some advantages over other stimulants in that it does not reduce the appetite or cause dry mouth.

Caratteristiche e vantaggi

This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Boehringer Ingelheim. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302 + H312 + H332

Classi di pericolo

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges, type P3 (EN 143) respirator cartridges

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Mark Olfson et al.
The Journal of clinical psychiatry, 74(1), 43-50 (2013-02-20)
The authors investigated trends and patterns in stimulant treatment of adults visiting office-based medical practices in the United States. A time series analysis of data from the 1994 to 2009 National Ambulatory Medical Care Surveys (no. of visits = 372,702)
Vera Peuckmann et al.
The Cochrane database of systematic reviews, (11)(11), CD006788-CD006788 (2010-11-12)
In healthy individuals, fatigue is a protective response to physical or mental stress, often relieved by rest. By contrast, in palliative care patients fatigue can be severely debilitating, thereby impacting daily activity and quality of life, often with rest not
Philip Shaw et al.
The American journal of psychiatry, 166(1), 58-63 (2008-09-17)
While there has been considerable concern over possible adverse effects of psychostimulants on brain development, this issue has not been examined in a prospective study. The authors sought to determine prospectively whether psychostimulant treatment for attention deficit hyperactivity disorder (ADHD)
Darragh P Devine
Methods in molecular biology (Clifton, N.J.), 829, 65-84 (2012-01-11)
Self-injurious behaviour is highly prevalent in neurodevelopmental disorders. Interestingly, it is not restricted to any individual diagnostic group. Rather, it is exhibited in various forms across patient groups with distinct genetic defects and classifications of disorders. This suggests that there
Coming into focus. Pharmacologic treatment for ADHD.
Mary Ann McDonnell et al.
Advance for NPs & PAs, 1(4), 16-22 (2011-02-16)
Visualizza tutti i documenti correlati

Articoli

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.